IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures Acceleration Network—Workshop…
Technology
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the…
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating delivery volume…
Unite to Fight the Flu – Influenza Season Update
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus, and the…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
FDA approves first quadrivalent vaccine to prevent seasonal influenza
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain four strains…
FDA announces agreement in principle on medical device user fees
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in principle on…
FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled because of…
IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures…
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps…
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive…
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating…
Unite to Fight the Flu – Influenza Season Update
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus,…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…
FDA approves first quadrivalent vaccine to prevent seasonal influenza
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain…
FDA announces agreement in principle on medical device user fees
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in…
FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.